- Report
- May 2026
- 294 Pages
Global
From €2307EUR$2,500USD£1,958GBP
- Report
- March 2026
- 170 Pages
Global
From €4475EUR$4,850USD£3,798GBP
- Report
- February 2026
- 260 Pages
Global
From €3333EUR$3,613USD£2,829GBP
€3922EUR$4,250USD£3,328GBP
- Report
- January 2024
- 150 Pages
Global
From €5490EUR$5,950USD£4,659GBP
- Report
- May 2025
- 120 Pages
Global
From €5490EUR$5,950USD£4,659GBP
- Report
- March 2024
- 200 Pages
Global
From €3829EUR$4,150USD£3,250GBP
- Report
- April 2024
- 115 Pages
Global
From €4152EUR$4,500USD£3,524GBP
- Report
- August 2022
- 120 Pages
Global
From €4152EUR$4,500USD£3,524GBP
- Report
- July 2025
- 82 Pages
United States
From €3229EUR$3,500USD£2,741GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2307EUR$2,500USD£1,958GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1845EUR$2,000USD£1,566GBP
- Report
- December 2024
- 152 Pages
Global
From €3645EUR$3,950USD£3,093GBP
- Report
- December 2024
- 30 Pages
Global
From €2537EUR$2,750USD£2,153GBP
- Report
- December 2024
- 30 Pages
Global
From €2537EUR$2,750USD£2,153GBP
- Report
- June 2024
- 200 Pages
Global
From €7336EUR$7,950USD£6,226GBP
- Report
- December 2024
- 30 Pages
Global
From €2537EUR$2,750USD£2,153GBP
- Report
- July 2024
- 150 Pages
Global
From €3460EUR$3,750USD£2,937GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2573EUR$2,789USD£2,184GBP
- Report
- April 2023
- 160 Pages
Global
From €4567EUR$4,949USD£3,875GBP
- Report
- April 2023
- 116 Pages
Global
From €4152EUR$4,500USD£3,524GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more